Krishna Komanduri, MD, FASTCT(@drkomanduri) 's Twitter Profile Photo

Now at UCSF Department of Medicine Grand Rounds Ajai Chari discussing the vexing problem of Parkinsonism arising after BCMA-targeted CAR-T therapies for with UCSF Helen Diller Family Comprehensive Cancer Ctr experts including Anupama Kumar characterizing the incidence and prognosis in our large treated population.

Now at @UCSFDOM Grand Rounds @AjaiChari discussing the vexing problem of Parkinsonism arising after BCMA-targeted CAR-T therapies for #myeloma with @UCSFCancer experts including @anupamakumar05 characterizing the incidence and prognosis in our large treated population. #Tcellrx
account_circle
British Journal of Haematology(@BrJHaem) 's Twitter Profile Photo

T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails! Joshua Richter, MD, FACP

onlinelibrary.wiley.com/doi/10.1111/bj…

T-cell redirection therapy after allogeneic stem cell transplantation in multiple myeloma: When the cure fails! @JoshuaRichterMD

onlinelibrary.wiley.com/doi/10.1111/bj… #mmsm #bmtsm #TCellRx
account_circle
Krishna Komanduri, MD, FASTCT(@drkomanduri) 's Twitter Profile Photo

At UCSF Department of Medicine Grand Rounds Babis Andreadis, MD, MSCE now discussing the unfortunate toxicities of including the CAR-T toxicities where ASTCT has taken the lead in defining categories of toxicities, also including late cytopenias, hemophagocytic syndromes and Parkinsonism.

At @UCSFDOM Grand Rounds @AndreadisBabis now discussing the unfortunate toxicities of #Tcellrx including the CAR-T toxicities where @ASTCT has taken the lead in defining categories of toxicities, also including late cytopenias, hemophagocytic syndromes and Parkinsonism. #lymphoma…
account_circle
CU Lymphoma Program(@CULymphoma) 's Twitter Profile Photo

manalikamdar Adam Olszewski MD Michael Wang, MD Dr. manalikamdar is also featured in several oral presentations on in , including liso-cel in follicular lymphoma as well as MCL, and the prognostic implications of ctDNA from the TRANSFORM trial.

@mana1981 @lymphomatic @michaelwangmd Dr. @mana1981 is also featured in several oral presentations on #celltherapy in #lymsm, including liso-cel in follicular lymphoma as well as MCL, and the prognostic implications of ctDNA from the TRANSFORM trial. #tcellrx #ASH23
account_circle
British Journal of Haematology(@BrJHaem) 's Twitter Profile Photo

Outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK improve over time

onlinelibrary.wiley.com/doi/10.1111/bj…

Outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK improve over time 

onlinelibrary.wiley.com/doi/10.1111/bj… 

#lymsm #TCellRx
account_circle
CU Lymphoma Program(@CULymphoma) 's Twitter Profile Photo

Our lymphoma faculty CU Anschutz Division of Hematology had several manuscripts published concurrently with ASH !
First, Drs. Ajay Major, MD, MBA & manalikamdar published an ASH Education manuscript on bispecific antibodies vs CAR-T in relapsed LBCL. /1
pubmed.ncbi.nlm.nih.gov/38066907/

Our lymphoma faculty @CUHematology had several manuscripts published concurrently with @ASH_hematology #ASH23!
First, Drs. @majorajay & @mana1981 published an ASH Education manuscript on bispecific antibodies vs CAR-T in relapsed LBCL. #lymsm #tcellrx /1
pubmed.ncbi.nlm.nih.gov/38066907/
account_circle